Geoffrey Beran Rose
Net Worth
Last updated:
What is Geoffrey Beran Rose net worth?
The estimated net worth of Mr. Geoffrey Beran Rose is at least $5,704,037 as of 2 Dec 2024. He owns shares worth $445,317 as insider, has earned $3,301,120 from insider trading and has received compensation worth at least $1,957,600 in Pulmonx Corporation.
What is the salary of Geoffrey Beran Rose?
Mr. Geoffrey Beran Rose salary is $391,520 per year as Chief Commercial Officer in Pulmonx Corporation.
How old is Geoffrey Beran Rose?
Mr. Geoffrey Beran Rose is 52 years old, born in 1973.
What stocks does Geoffrey Beran Rose currently own?
As insider, Mr. Geoffrey Beran Rose owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | Chief Commercial Officer | 291,057 | $1.53 | $445,317 |
What does Pulmonx Corporation do?
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Geoffrey Beran Rose insider trading
Pulmonx Corporation
Mr. Geoffrey Beran Rose has made 58 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,538 units of LUNG stock worth $9,505 on 2 Dec 2024.
The largest trade he's ever made was exercising 49,428 units of LUNG stock on 18 May 2021. As of 2 Dec 2024 he still owns at least 291,057 units of LUNG stock.
Pulmonx key executives
Pulmonx Corporation executives and other stock owners filed with the SEC:
- Mr. David A. Lehman (64) Gen. Counsel & Sec.
- Mr. Geoffrey Beran Rose (52) Chief Commercial Officer
- Mr. Glendon E. French (63) Chief Executive Officer, Pres & Director